SEC Form 4 · accession 0001237899-15-000041
REGENERON PHARMACEUTICALS, INC. · REGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marc Tessier-Lavigne
Director
Period of report
Aug 5, 2015
Accepted (ET)
Aug 5, 2015 · 8:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000872589
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 5, 2015 | M | 5,000 | $57.11 | A | 6,187 | D | |
| Common StockF1 | Aug 5, 2015 | S | 1,500 | $584.07 | D | 4,687 | D | |
| Common StockF2 | Aug 5, 2015 | S | 1,000 | $590.17 | D | 3,687 | D | |
| Common StockF3 | Aug 5, 2015 | S | 2,000 | $593.64 | D | 1,687 | D | |
| Common StockF4 | Aug 5, 2015 | S | 500 | $595.44 | D | 1,187 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F5 | $57.11 | Aug 5, 2015 | M | 5,000 | D | — | Jan 3, 2022 | Common Stock | 5,000 | 5,000 | D |
Explanation of responses
- F1Represents volume-weighted average price of sales of 1,500 shares of Company stock on August 5, 2015 at prices ranging from $584.00 to $584.16. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 5, 2015 at each separate price.
- F2Represents volume-weighted average price of sales of 1,000 shares of Company stock on August 5, 2015 at prices ranging from $590.00 to $590.70. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 5, 2015 at each separate price.
- F3Represents volume-weighted average price of sales of 2,000 shares of Company stock on August 5, 2015 at prices ranging from $593.33 to $593.80. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 5, 2015 at each separate price.
- F4Represents volume-weighted average price of sales of 500 shares of Company stock on August 5, 2015 at prices ranging from $595.22 to $595.64. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 5, 2015 at each separate price.
- F5The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.